Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

This study was undertaken to examine the experiences and perspectives of Indigenous Peoples who use illicit drugs (IPWUID) in the Downtown Eastside of Vancouver regarding the drug poisoning crisis

Original research | 2024
About PWUD, Equity, Harm reduction, Illegal drugs, Indigenous, Legal system/law enforcement, Overdose, Peer/PWLLE program involvement, Poverty

The current qualitative study examines the perspectives of women with opioid use disorder (OUD) and professionals that serve them on barriers to engaging in overdose prevention and harm reduction p

Original research | 2024
Harm reduction, Illegal drugs, Naloxone, Overdose, Substitution/OAT

Drugs sold on cryptomarkets are thought to have lower levels of adulteration and higher strength compared with those sourced off-line.

Original research | 2024
Drug checking, Illegal drugs, Hallucinogens/psychedelics, Stimulants

The Community Urinalysis and Self-Report Project (CUSP) is a low-barrier sentinel surveillance system developed to better understand use of drugs from the unregulated supply.

Report | 2024
About PWUD, Benzodiazepines, Drug checking, Illegal drugs, Injecting drugs, Opioids, Stimulants

Is compulsory unpaid labor essential addiction “therapy” or unjust exploitation?

Original research | 2024
About PWUD, Stigma, Workplace, Treatment/recovery

In an Indigenous Health Service hospital in rural Minnesota, the pharmacy sought to integrate harm reduction and express Sexually Transmitted Infections (STIs) services into its scope of practice.

Report | 2024
About pharmacists, Barriers and enablers, Harm reduction, Indigenous

The number of overdose deaths since 1999 has steadily increased in large part due to the presence of synthetic opioids in the US drug supply.

Commentary | 2024
About prescribers, Hospitals, Illegal drugs, Overdose, Substitution/OAT, Transitions in care/treatment, Treatment/recovery

Safer supply programs are intended to reduce overdose events by limiting people's use of the contaminated drug supply, but the experiences of people receiving hydromorphone vary.

Original research | 2024
About PWUD, Advocacy, Barriers and enablers, Chronic pain, Harm reduction, Injecting drugs, Mental health, Opioids, Overdose, Stigma, Safer supply, Withdrawal

This study aimed to estimate the risk of opioid-related poisonings and mental and behavioural disorders by occupation and industry within a cohort of 1.7 million formerly injured workers.

Original research | 2024
Evidence base, Mental health, Hospitals, Illegal drugs, Opioids, Overdose

In the US context of an unprecedented magnitude of drug overdose deaths and during the fentanyl era, it becomes increasingly imperative to identify longitudinal predictors to inform targeted preven

Original research | 2024
About PWUD, Hospitals, Injecting drugs, Naloxone, Overdose, Substitution/OAT

To assess the risk of treatment discontinuation and mortality among individuals receiving buprenorphine/naloxone vs methadone for the treatment of opioid use disorder.

Original research | 2024
About PWUD, Clinical guidance, Mortality, Opioids, Outcomes, Substitution/OAT, Treatment/recovery

This study aimed to estimate the strength of association between prescriptions of glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon-like peptide-1 receptor agonists (GLP-1 RA) and

Original research | 2024
About PWUD, Alcohol, Evidence base, Opioids, Outcomes, Overdose

To assess the 2-year layperson-administered naloxone (LAN) trend for persons in the United States receiving naloxone during emergency medical services (EMS) activations.

Original research | 2024
Advocacy, Harm reduction, Naloxone, Opioids, Overdose

This guide provides information and strategies to primary care providers on harm reduction as a trauma informed approach to treating individuals with substance use disorder.

Guide or handbook | 2023
2SLGBTQI+, About prescribers, Drug checking, Equity, Harm reduction, Illegal drugs, Injecting drugs, Opioids, Overdose, SCS/OPS, Stigma

This study examined how and why primary care systems may be suited towards, or pose challenges to providing OUD care, and identified health system opportunities to address these challenges.

Original research | 2024
About prescribers, Barriers and enablers, Hesitancy of prescribers , Policy/Regulatory, Primary care, Stigma, Substitution/OAT, Transitions in care/treatment

Literature, best practices and media narratives can be readily found for people with substance use disorders (SUD), however much less is known across Canada about how to support the substance use h

Report | 2024
About PWUD, Advocacy, Barriers and enablers, Peer/PWLLE program involvement, Policy/Regulatory, Stigma

In the province of Alberta, new regulations introduced in 2022 significantly constrain safer supply prescribing by banning the prescription, dispensing, and administration of safer supply outside o

Commentary | 2024
About people who use drugs, About prescribers, Advocacy, Diversion, Harm reduction, Hesitancy of prescribers , Illegal drugs, Opioids, Overdose, Policy/Regulatory, Safer supply, Stigma, Substitution/OAT

This scoping review synthesizes barriers and facilitators to buprenorphine initiation in the ED, and uses the Consolidated Framework for Implementation Research and a critical lens to analyze the l

Scoping review | 2024
Barriers and enablers, Diversion, Harm reduction, Hesitancy of prescribers , Hospitals, Overdose, Peer/PWLLE program involvement, Stigma, Substitution/OAT, Transitions in care/treatment, Withdrawal

This lab-based study aimed at evaluating lateral flow immunoassay nitazene test strips (NTS; BTNX Rapid Response™) for their potential in drug checking applications.

Original research | 2024
Drug checking, Evidence base, Illegal drugs, Opioids

Conceptualizing the Emergency Department (ED) as a complex adaptive system, this paper examines how ED staff experience opioid-specific harm reduction provision and engage in harm reduction practic

Original research | 2024
About prescribers, About nurses, Advocacy, Barriers and enablers, Harm reduction, Hesitancy of prescribers , Hospitals, Injecting drugs, Overdose, Stigma, Substitution/OAT, Transitions in care/treatment, Withdrawal

Refine Your Search

Keywords
Format
Region